208 related articles for article (PubMed ID: 20640899)
1. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation.
Katahira K; Takahara T; Kwee TC; Oda S; Suzuki Y; Morishita S; Kitani K; Hamada Y; Kitaoka M; Yamashita Y
Eur Radiol; 2011 Jan; 21(1):188-96. PubMed ID: 20640899
[TBL] [Abstract][Full Text] [Related]
2. Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI.
Ueno Y; Kitajima K; Sugimura K; Kawakami F; Miyake H; Obara M; Takahashi S
J Magn Reson Imaging; 2013 Jul; 38(1):154-60. PubMed ID: 23292979
[TBL] [Abstract][Full Text] [Related]
3. Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.
Zhang K; Shen Y; Zhang X; Ma L; Wang H; An N; Guo A; Ye H
PLoS One; 2016; 11(3):e0151176. PubMed ID: 26963936
[TBL] [Abstract][Full Text] [Related]
4. Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
Doo KW; Sung DJ; Park BJ; Kim MJ; Cho SB; Oh YW; Ko YH; Yang KS
Eur Radiol; 2012 Aug; 22(8):1812-9. PubMed ID: 22466514
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of diffusion-weighted magnetic resonance imaging for localization of prostate cancer--comparison with the step sections of radical prostatectomy].
Hatano K; Tsuda K; Kawamura N; Kakuta Y; Takada T; Adachi S; Hara T; Yamaguchi S
Nihon Hinyokika Gakkai Zasshi; 2010 May; 101(4):603-8. PubMed ID: 20535988
[TBL] [Abstract][Full Text] [Related]
7. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
8. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.
Lim HK; Kim JK; Kim KA; Cho KS
Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection.
Gholizadeh N; Greer PB; Simpson J; Goodwin J; Fu C; Lau P; Siddique S; Heerschap A; Ramadan S
J Biomed Sci; 2021 Jul; 28(1):54. PubMed ID: 34281540
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
12. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization.
Rosenkrantz AB; Mannelli L; Kong X; Niver BE; Berkman DS; Babb JS; Melamed J; Taneja SS
J Magn Reson Imaging; 2011 Jul; 34(1):95-100. PubMed ID: 21698707
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of diffusion-weighted imaging in the localization of prostate cancer.
Kajihara H; Hayashida Y; Murakami R; Katahira K; Nishimura R; Hamada Y; Kitani K; Kitaoka M; Suzuki Y; Kitajima M; Hirai T; Morishita S; Awai K; Yamashita Y
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):399-403. PubMed ID: 19019564
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?
Iwazawa J; Mitani T; Sassa S; Ohue S
Diagn Interv Radiol; 2011 Sep; 17(3):243-8. PubMed ID: 20859852
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted magnetic resonance imaging combined with T2-weighted images in the detection of small breast cancer: a single-center multi-observer study.
Wu LM; Chen J; Hu J; Gu HY; Xu JR; Hua J
Acta Radiol; 2014 Feb; 55(1):24-31. PubMed ID: 23878358
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.
Kim CK; Choi D; Park BK; Kwon GY; Lim HK
J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer.
Ohgiya Y; Suyama J; Seino N; Hashizume T; Kawahara M; Sai S; Saiki M; Munechika J; Hirose M; Gokan T
Clin Imaging; 2012; 36(5):526-31. PubMed ID: 22920357
[TBL] [Abstract][Full Text] [Related]
20. Image Quality Assessment of 2D
Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
